“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
BBO-10203 physically and allosterically disrupts the interaction between RAS and PI3Kα, leading to signaling inhibition without inhibiting the ...
BBO-11818 targets KRAS in both its ON (active GTP-bound) and OFF (inactive GDP-bound) states, potently suppressing MAPK ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Background Sympathetic signalling plays a critical role in the initiation and progression of various malignancies. However, ...
Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...
A key protein, HOXD13, helps melanoma tumors grow and evade the immune system by boosting blood supply and blocking cancer-fighting T cells. Disabling it shrinks tumors and reopens the door for the ...
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...
Fragile X syndrome (FXS) is an inherited genetic developmental condition that strongly impacts brain development. Despite the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results